Literature DB >> 25142877

Coenzyme Q10 increases cholesterol efflux and inhibits atherosclerosis through microRNAs.

Ryan M Allen1, Kasey C Vickers2.   

Abstract

Entities:  

Keywords:  CoQ 10; high-density lipoproteins; microRNA

Mesh：

Substances：

Year:  2014        PMID： 25142877      PMCID： PMC4142520          DOI： 10.1161/ATVBAHA.114.303741

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  24 in total

1.  Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.

Authors:  Snehal U Naik; Xun Wang; Jaqueline S Da Silva; Michael Jaye; Colin H Macphee; Muredach P Reilly; Jeffrey T Billheimer; George H Rothblat; Daniel J Rader
Journal:  Circulation       Date:  2005-12-19       Impact factor: 29.690

2.  Coenzyme Q10 promotes macrophage cholesterol efflux by regulation of the activator protein-1/miR-378/ATP-binding cassette transporter G1-signaling pathway.

Authors:  Dongliang Wang; Xiao Yan; Min Xia; Yan Yang; Dan Li; Xinrui Li; Fenglin Song; Wenhua Ling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03-27       Impact factor: 8.311

3.  Prevention of coronary atherosclerosis by the use of combination therapy with antioxidant coenzyme Q10 and statins.

Authors:  G Chapidze; S Kapanadze; N Dolidze; Z Bachutashvili; N Latsabidze
Journal:  Georgian Med News       Date:  2005-01

Review 4.  Atherosclerosis.

Authors:  A J Lusis
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

Review 5.  Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia.

Authors:  Simon W Beaven; Peter Tontonoz
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

6.  Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA.

Authors:  A E Pasquinelli; B J Reinhart; F Slack; M Q Martindale; M I Kuroda; B Maller; D C Hayward; E E Ball; B Degnan; P Müller; J Spring; A Srinivasan; M Fishman; J Finnerty; J Corbo; M Levine; P Leahy; E Davidson; G Ruvkun
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

7.  Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice.

Authors:  P K Witting; K Pettersson; J Letters; R Stocker
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

8.  Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study.

Authors:  G Ghirlanda; A Oradei; A Manto; S Lippa; L Uccioli; S Caputo; A V Greco; G P Littarru
Journal:  J Clin Pharmacol       Date:  1993-03       Impact factor: 3.126

Review 9.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

10.  LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.

Authors:  Lars Verschuren; Jitske de Vries-van der Weij; Susanne Zadelaar; Robert Kleemann; Teake Kooistra
Journal:  J Lipid Res       Date:  2008-08-30       Impact factor: 5.922
View more
  4 in total

1.  MicroRNA-590 Inhibits Lipoprotein Lipase Expression and Prevents Atherosclerosis in apoE Knockout Mice.

Authors:  Ping-Ping He; Xin-Ping OuYang; Yuan Li; Yun-Cheng Lv; Zong-Bao Wang; Feng Yao; Wei Xie; Yu-Lin Tan; Liang Li; Min Zhang; Gang Lan; Duo Gong; Hai-Peng Cheng; Hui-Juan Zhong; Dan Liu; Chong Huang; Zhao-Xia Li; Xi-Long Zheng; Wei-Dong Yin; Chao-Ke Tang
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

Review 2.  Atherosclerosis and Coenzyme Q10.

Authors:  Juan M Suárez-Rivero; Carmen J Pastor-Maldonado; Mario de la Mata; Marina Villanueva-Paz; Suleva Povea-Cabello; Mónica Álvarez-Córdoba; Irene Villalón-García; Alejandra Suárez-Carrillo; Marta Talaverón-Rey; Manuel Munuera; José A Sánchez-Alcázar
Journal:  Int J Mol Sci       Date:  2019-10-20       Impact factor: 5.923

Review 3.  Translational and Therapeutic Approaches to the Understanding and Treatment of Dyslipidemia.

Authors:  Hanrui Zhang; Thomas Q de Aguiar Vallim; Catherine Martel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07       Impact factor: 10.514

4.  CoQ10 supplementation rescues nephrotic syndrome through normalization of H2S oxidation pathway.

Authors:  Giulio Kleiner; Emanuele Barca; Marcello Ziosi; Valentina Emmanuele; Yimeng Xu; Agustin Hidalgo-Gutierrez; Changhong Qiao; Saba Tadesse; Estela Area-Gomez; Luis C Lopez; Catarina M Quinzii
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-06       Impact factor: 6.633
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.